Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Shanghai Pulmonary Hospital, Shanghai, China

8 clinical trials · 8 recruiting · OTHER

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Trials by Shanghai Pulmonary Hospital, Shanghai, China

RECRUITINGPhase 2NCT07410975

Efficacy of Anti-CTLA-4 Antibody Combined With Sintilimab and Chemotherapy as Neoadjuvant Therapy for Resectable Stage...

This study aims to evaluate the major pathologic response (MPR) rate of neoadjuvant therapy with sintilimab (PD-1 inhibitor) + IBI310 (anti-CTLA-4 antibody) + chemotherapy, and to...

Sponsor: Shanghai Pulmonary Hospital, Shanghai, ChinaEnrolling: 541 location
NSCLC Stage IINSCLC Stage III
RECRUITINGNCT07243873

Synthetic PET From CT Improves Precision Diagnosis and Treatment of Lung Cancer: a Prospective, Observational,...

This study aims to synthesise PET data that preserves biological relevance and adds clinical value to the diagnosis and prognosis of lung cancer by establishing...

Sponsor: Shanghai Pulmonary Hospital, Shanghai, ChinaEnrolling: 100005 locations
Lung CancerPET-CT
RECRUITINGNCT05604495

Screening for Cystic Fibrosis and Cystic Fibrosis Related Disorders in Chinese Adults With Bronchiectasis

The study carries out Sweet Tests and CFTR-mutation screening to explore the prevalence, clinical characteristics, and prognosis of cystic fibrosis, as well as the CFTR-mutation...

Sponsor: Shanghai Pulmonary Hospital, Shanghai, ChinaEnrolling: 10001 location
Cystic Fibrosis, Pulmonary
RECRUITINGPhase 4NCT05493267

A Exploratory Study of Vγ2Vδ2 T Lymphocyte-based Immunotherapy for MDR-TB

A Exploratory Study of drug combination (zoledronic acid/interleukin 2) that specifically amplifies Vγ2Vδ2 T cells in combination with anti-tuberculosis chemotherapy for the...

Sponsor: Shanghai Pulmonary Hospital, Shanghai, ChinaEnrolling: 302 locations
MDR-TBImmunotherapy
RECRUITINGNCT06900062

The C-BRIDGE Study: China Bronchiectasis Research Involving Databases, Genomics, and Endotyping

Bronchiectasis is a heterogeneous airway disease with diverse causes, making precise diagnosis, prognosis, and treatment response prediction challenging. Identifying patient...

Sponsor: Shanghai Pulmonary Hospital, Shanghai, ChinaEnrolling: 15009 locations
Bronchiectasis Adult
RECRUITINGNCT06760273

Long-term Impact of Inhaled Tobramycin for Pseudomonas Aeruginosa Eradication in Bronchiectasis (ERASE II)

The ERASE II study is a prospective follow-up study designed to assess the long-term impact of successful eradication of Pseudomonas aeruginosa (PA) in patients with...

Sponsor: Shanghai Pulmonary Hospital, Shanghai, ChinaEnrolling: 36420 locations
Bronchiectasis Adult
RECRUITINGPhase 4NCT06093191

Tobramycin Inhalation Solution for Pseudomonas Aeruginosa Eradication in Bronchiectasis

People with bronchiectasis are prone to Pseudomonas aeruginosa (PA) infections, which can become chronic and lead to increased death rates and disease severity. Studies from...

Sponsor: Shanghai Pulmonary Hospital, Shanghai, ChinaEnrolling: 36420 locations
Bronchiectasis AdultPseudomonas Aeruginosa Infection
RECRUITINGNCT06393257

Airway Clearance Technique of Oscillation and Lung Expansion in Bronchiectasis

The goal of this prospective randomized controlled trial is to explore the efficacy and safety of Oscillation and Lung Expansion-a airway clearance technology-in bronchiectasis....

Sponsor: Shanghai Pulmonary Hospital, Shanghai, ChinaEnrolling: 963 locations
Bronchiectasis Adult